Cerebral amyloid β-peptide (Aβ) accumulation resulting from an imbalance between Aβ production and clearance is one of the most important causes in the formation of Alzheimer's disease (AD). In order to preserve the maintenance of Aβ homeostasis and have a notable AD therapy, achieving a method to clear up Aβ plaques becomes an emerging task. Herein, we describe a self-destructive nanosweeper based on multifunctional peptide-polymers that is capable of capturing and clearing Aβ for the effective treatment of AD. The nanosweeper recognize and bind Aβ via co-assembly through hydrogen bonding interactions. The Aβ-loaded nanosweeper enters cells and upregulates autophagy thus promoting the degradation of Aβ. As a result, the nanosweeper decreases the cytotoxicity of Aβ and rescues memory deficits of AD transgenic mice. We believe that this resourceful and synergistic approach has valuable potential as an AD treatment strategy.
A lzheimer's disease (AD) has been considered the most pervasive neurodegenerative disorder, affecting a great number of humans worldwide [1] [2] [3] . The emphatic pathological hallmarks of AD are extracellular deposits of selfassembled fibrils based on the amyloid β-peptide (Aβ) and intracellular neurofibrillary tangles containing hyperphosphorylated tau [4] [5] [6] [7] [8] . Over the past few decades, the trend in therapeutic methods for AD involved inhibiting the self-assembly of Aβ into fibrils and thus the resultant deposition of Aβ. Intense research indicates that inhibitors, such as antibodies 9 , peptidebased nanomaterials [10] [11] [12] , small molecules 13, 14 , and various nanoparticles [15] [16] [17] , can decelerate the aggregation of Aβ. However, the recent failure of clinical trials based on bapineuzumab 18 and solanezumab 19 suggests that there is still a long way to go in treatment of AD against Aβ 20, 21 . It has been accepted, when considering AD therapeutics, that the clearance of Aβ is the essential component in the maintenance of Aβ homeostasis. Autophagy, the way by which cells degrade their own metabolites, may be applied for Aβ clearance. Indeed, the dysfunction of the autophagy-lysosome system leads to the accumulation of Aβ 22, 23 . It is beneficial for the enhancement of Aβ clearance that the induction of autophagy is appropriately elevated, giving rise to the distinct implication of autophagy as a therapeutic strategy [23] [24] [25] . However, because Aβ generated from amyloid precursor protein (APP) in endosomes is recycled to the cell surfaces and usually aggregates and deposits outside the cell while autophagic degradation occurs intracellularly, the concept of Aβ clearing by autophagy is contradictory.
Herein, we design a nanosweeper with the goal of effectively degrading extracellular Aβ, and find that it not only captures extracellular Aβ and carries Aβ into cells, but it also upregulates cellular autophagy and digestes Aβ. The nanosweeper is composed of a cationic chitosan (CS) core decorated with PEGylated-GKLVFF (designated as K) and Beclin-1 (TGFQGSHWIHFTANFVNT, designated as B). KLVFF can recognize and co-assemble with Aβ through hydrogen-bonding interactions. Beclin-1 can induce autophagy to degrade Aβ. The polyethylene glycol (PEG) increases the dispersity of the nanosweeper in water, providing the appropriate biocompatibility and stability. First, the nanosweeper captures and co-assembles with extracellular Aβ specifically, inhibiting the formation of toxic Aβ aggregates remarkably. Next, the nanosweeper preferentially delivers Aβ into cells and activates autophagy within them to degrade Aβ, ultimately resulting in Aβ clearance (Fig. 1) . Results from in vitro and in vivo experiments confirms the nanosweeper's high-efficiency for Aβ clearance. Among the Aβ-treated cells, the nanosweeper increases the cell viability from approximately 60 to 93%. Furthermore, the insoluble Aβ is decreased from 1539 to 914 ng/mg, and soluble Aβ is decreased from 585 to 190 ng/mg in the brain of AD transgenic mice treated with the nanosweeper, leading to rescued memory deficits. This delicate nano-strategy can be a potential therapeutic approach in the treatment of AD.
Results

Preparation of the nanosweeper.
A series of nanosweepers with various chemical compositions were established by changing the peptide ratios 26 . There were two functional peptide analogs, a KLVFF peptide that could recognize and bind with Aβ 42 27, 28 , and a Beclin1 peptide that could significantly induce autophagy 29, 30 . Both functional peptides were applied for linking with chitosan (CS) that was first modified by acrylate (acryl-CS). To control the hydrophobic/hydrophilic balance of the nanosweeper, PEG 368 was used to modify the G residue of the GKLVFF peptide. As shown in Fig. 2a , the feed molar ratios of KLVFF (Supplementary Fig. 1 ) and Beclin-1 were adjusted to obtain polymers with various peptide ratios. The final products were designated as M 1 (20 μM) in the absence or presence of M 1-5 (20 μg·mL −1 ). As shown in Fig. 1c , Aβ 42 alone exhibited obvious toxicity (cell viability, 59.3%), which confimred the findings of previous reports 6, 31, 32 . However, adding nanosweepers reduced the toxicity of Aβ 42 . M 2-4 containing both K and B treated groups showed remarkably higher cell viabilities (*p < 0.05, **p < 0.01, ***p < 0.001, Student's t-test) than M 1 and M 5 treated groups, which only contains either K or B. This difference in cell viabilities indicated that the combination of both functional peptides resulted in a synergistic anti-Aβ-toxicity effect. M 3 showed the highest cell viability (92.5%), close to that of the control group (100%) and was screened as the potential lead nanosweeper for clearance of Aβ and AD treatment.
To further verify the synergistic anti-Aβ toxicity effect of M 3 , two control peptide-polymers were prepared, M K , in which the Beclin-1 peptide was replaced by a control peptide without autophagy activation functionality, and M B , in which the KLVFF peptide was replaced by a KAAGG peptide without Aβ capture functionality ( Supplementary Fig. 3 ). The chemical structures of both control peptide-polymers were also confirmed by 1 H NMR spectra ( Supplementary Fig. 4 ). The cell viability results of M K (78.0%) and M B (80.9%) implied that they had lower anti-Aβ toxicity than M 3 ( Supplementary Fig. 5 ), which indicated that the enhanced anti-Aβ-toxicity seen with M 3 originated from the synergistic effect of KLVFF and Beclin-1. 42 by the nanosweeper. In order to study the ability of the nanosweeper to regognize and co-assemble with Aβ 42 , we first employed the Thioflavin T (ThT) fluorescence assay to detect Aβ fibril formation in the presence of M 3 . The ThT assay, an established method of dye binding, was applied to monitor Aβ 42 aggregation because its fluorescent spectrum can be altered with the growth of fibrils 6 . Figure 3a displays a series of sigmoidal curves which are typical of Aβ 42 fibrillation. The fluorescence intensity of neat Aβ 42 was higher due to the larger amount of Aβ 42 fibrillation formation than that of Aβ 42 in the presence of M 3 , which was similar to the result observed with M K , and much lower than that observed with M B. The decreasing ThT fluorescence seen from M 5 to M 1, together with the increasing KLVFF content (Supplementary Fig. 6 ), validated the recognition and co-assembly functionality of KLVFF, resulting in the inhibition of Aβ 42 dichromism (CD) spectra confirmed that M 3 inhibited the formation of β-sheet structrured Aβ 42 fibrils (Fig. 3b) . The Aβ 42 showed random structures at 0 h ( Supplementary Fig. 7 ) and typical β-sheet structure at 24 h, with positive and negative signals at 195 and 216 nm, respectively. The M 3 or M K treated Aβ did not show typical β-sheet structures at 24 h, however, the M B treated Aβ 42 did show typical β-sheet structures at 24 h. The CD measurements also revealed the inhibitory effect of Aβ 42 fibrillation due to KLVFF recognition and co-assembly.
Capture of Aβ
To provide evidence for supporting the binding effect of M 3 to Aβ 42 , transmission electron microscopy (TEM) and dynamic light scattering (DLS) were exploited to detect the evolution of morphology and size distribution in an Aβ 42 showed similar particulate structures with 43.8 ± 11.1 nm diameter at 24 h (Fig. 3c, d and Supplementary Fig. 8a ), and their surfaces could be composed by relative hydrophilic PEG 368 -GKLVFF (or PEG 368 -GKAAGG). Following a 24 h incubation with Aβ 42 at 37°C, TEM images showed that Aβ 42 incubated with M B clearly contained separate morphologies of nanoparticles and nanofibers (Fig. 3e) at 24 h, which were potentially originated from M B and Aβ 42 (Fig. 3f) , respectively. However, the Aβ 42 incubated with M 3 and M K contained main species of particulate structures entangled with some fibers (Fig. 3g and Supplementary  Fig. 8b ), the morphology of which was totally different from free mature Aβ 42 fibrils. Interestingly, the statistics obtained from the fiber length taken from the TEM images of Aβ 42 , and Aβ 42 /M B showed similar lengths, 225 ± 109 and 191 ± 60 nm (Fig. 3h) Supplementary Fig. 11 ). However, there were no obvious colocalization observed between M B -Cy5 and Aβ 42 -FITC, indicating that the KLVFF induced the co-assembly of M 3 /M K and Aβ 42 . In order to confirm the specificity, Cy3.5-labeled bovine serum albumin (BSA), a kind of serum albumin, accoutning for 55% of blood proteins, was utilized as a competing regent. The M 3 -Cy5, Aβ 42 -FITC, and BSA-Cy3.5 were mixed together, and observed by CLSM. The results clearly displayed that the M 3 -Cy5 co-localized with Aβ 42 -FITC, but not BSA-Cy3.5, providing strong evidence for the specific co-assembly between M 3 -Cy5 and Aβ 42 -FITC (Fig. 3i,j) . Fig. 13 ). These results suggested that M B entered the cells alone, and that the Aβ 42 -FITC stuck on cell surfaces as usual. When cell surfaces were covered with Aβ 42 -FITC, the M B -Cy5 may no longer be able to enter cells, but stayed on cell surfaces, showing the merged fluorescence signals on cell surfaces. Therefore, the co-assembly of M 3 and Aβ 42 not only inhibited the Aβ 42 fibril formation, but also increased the internalization of Aβ 42 .
Inducement of autophagy by the nanosweeper in vitro. In order to validate the autophagy effect of M 3 on N2a cells, autophagic structures and the marker protein LC3-II were measured using Acridine Orange staining, Bio-TEM, and western blot methods. Acridine Orange (AO) is a pH-sensitive dye and typically used as non-specific chemical agent for autophagy detection. It can mark acidic vesicular organelles with red and cytoplasm and DNA with green 30 . The ratio of red/green has been used widely to evaluate levels of autophagy 33, 34 . The N2a cells were incubated with M 3 , and M B and M K as controls for 4 h, then stained with AO dyes for 10 min, followed by observation by CLSM. As shown in Supplementary Fig. 14b , ***p < 0.001).
In addition, bio-TEM, a standard method for autophagy detection, was applied to examine the autophagic structures (autophagosome and autolysosome) of N2a cells. The N2a cells were first treated with M 3 , M K and M B for 4 h, after which the cells were harvested and prepared for bio-TEM imaging using our previous method 35 . Finally, a JEOL JEM-1400 electron microscope was used to observe cells. As shown in Fig. 5a , an increase in the amount of small double/multi-membrane vesicles (autophagosome, black arrow) and huge vacuoles (autolysosome, white arrow) were observed in the M 3 -treated and M B -treated cells, compared with the PBS group. However, there were minimal autophagic structures in the M K -treated cells. The statistic results showed dramatic differences between M K and M 3 treated groups (Fig. 5b , *p < 0.05 Student's t-test). In addition, the results of western blotting for LC3-II, an autophagy marker protein, confirmed that M 3 increased the expression of LC3-II significantly (Fig. 5c, d) . The above results lent strong support to the hypothesis that Beclin-1 residues in M 3 could effectively induce autophagy in vitro.
Autophagic degradation induced by the nanosweeper in vitro.
We studied the autophagic flux of N2a cells in order to explore whether or not intracellular M 3 &Aβ 42 adduct could be degraded by the autophagic process. M 3 was first labeled with Cy5 (red signal). Next, the GFP-LC3 transfected N2a cells were incubated with M 3 -Cy5&Aβ 42 (20 μg·mL −1 /20 μM) for 4 h, followed by CLSM observation. Generally, LC3-II was recruited to the autophagosome membrane and thereby formed a green dot of GFP-LC3 when autophagy was activated 36, 37 . As expected, the CLSM images revealed that most of the M 3 -Cy5 (red signal) colocalized with autophagosomes (GFP-LC3, green signal) (Fig. 6a) , indicating that M 3 &Aβ 42 was delivered to autophagosomes. Generally, the autophagosome would be fused with the lysosome, forming an autolysosome for degredation of cargo 38 . So, we therefore measured the colocalization of M 3 -Cy5&Aβ 42 with autolysosomes. p62, An autolysosome marker protein that is preferentially degraded by autophagic process, was marked with green fluorescence through an immunofluorescence technique. The results displayed that the green immunofluorescence signals from p62 and red fluorescence signals from M 3 -Cy5 were highly merged (Fig. 6b) , indicating that M 3 &Aβ 42 was transferred into the autolysosome for degradation (Fig. 6c) . To further confirm autophagic degradation, we used western blotting to detect the autophagic flux based on expression of p62. As shown in Fig. 6d , M 3 upregulated the expression of p62, similarly to HCQ and Rapa. However, M 3 did not induce obvious p62 upregulation of the Rapa-treated group, but increased accumulation of p62 in the HCQ-treated group, with a p62/β-actin ratio from 2.58 to 3.10 Crossing BBB and activating autophagy in vivo. For the in vivo experiment, the nanosweeper should be effectively delivered into brain. Cyclosporine was verified to effectively increase the permeability of blood-brain barrier (BBB) through influencing P-gp function in the BBB 39, 40 . In order to evaluate how M 3 nanosweeper crossed the BBB, we intravenously injected cyclosporine (10 μM) into mice, followed by i.v. administration of a dose of 200 μg·mL −1 M 3 nanosweeper, which was labeled by Cy5. The mice were sacrificed and the brains were harvested for ex vivo imaging. As shown in Supplementary Fig. 15 , the higher fluorenscence signal in cyclosporine and M 3 -Cy5 nanosweepers indicated that cyclosporine made more M 3 nanosweepers reaching to the brain, compared with PBS or M 3 -Cy5 nanosweeper treated group. Furthermore, for quantifying the efficiency of M 3 nanosweepers crossing BBB, we loaded the very small gold NPs into M 3 nanosweepers, and i.v. injected into the mice 30 min after cyclosporine i.v. administration. The M 3 nanosweepers distribution in the brain was characterized by gold amount, which was measured by inductively coupled plasma mass spectrometry. M 3 nanosweepers reaching the brain could be calculated as 1.94% of total injection (Fig. 7a) . The activation of autophay in the brain determined the therapeutic effect, the immunohistochemical method was utilized for confirming the autophagic process of hippocampal neuron activated by M 3 nanosweepers. Sections of the hippocampi from mice were stained with LC3 antibody marked with FITC. The CLSM images displayed an increased dots of green signals (autophagic structures) in the M 3 -treated mice than that of the wild type (WT) and AD groups (Fig. 7b) , indicating the more LC3, the biomarker of autophagy in M 3 treated mice brain. In addition, brain slices of AD mice treated with M 3 were observed by bio-TEM, and the results were shown in Fig. 7c Clearance of Aβ and rescue of memory deficits. In order to further study whether or not the M 3 nanosweeper could reduce amyloid plaques in the brains of AD mice, M 3 nanosweeper was utilized to treat APPswe/PS1dE9 transgenic mice every other day for one month 15, 16, 41 . Following the treatment period, the amount of soluble Aβ 42 and insoluble Aβ 42 in the brain tissue was measured by enzyme-linked immune sorbent assay (ELISA) (Fig. 8a,b Fig. 8c , a large amount of Aβ deposition (circled with red dotted line) was observed in the AD control mice, and the difference was obvious between those and the WT control mice. Importantly, in the brains of AD mice treated with M 3 nanosweeper, there was a significant decrease in the Aβ plaque load, indicating that M 3 nanosweeper had the ability to reduce Aβ deposition, which was in agreement with the measurments of Aβ in the brain. The soluble and insoluble Aβ in the brain of AD mice treated with M 3 was also decreased (Supplementary Fig. 16 ), but not as much as the extend of decrease in Aβ 42 , probably indicating the specificity of M 3 for capture of Aβ 42 by KLVFF. The results of Nissl staining of nerve cells revealed an obvious neuronal hypocellularity in the brain of AD control mice, which had small amounts of Nissl bodies (blue) (Fig. 8d) . Contrastingly, M 3 nanosweeper treatment significantly attenuated neuron loss in AD mice. Together, these results indicated that M 3 nanosweeper could effectively decrease soluble Aβ 42 and insoluble Aβ 42 , as well as the the deposition of Aβ and toxicity in nerve cells.
The Morris water maze (MWM) test was utilized to investigate the effect of M 3 nanosweeper on the spatial cognitive performance of APPswe/PS1dE9 transgenic mice. The escape latencies of M 3 -treated mice for searching for the hidden platform were measured daily for 4 days. As shown in Fig. 8e , both WT mice and M 3 nanosweeper-treated AD mice exhibited significantly shorter latency than the AD control group on days 2, 3, and 4, indicating that M 3 nanosweeper could markedly improve the spatial memory of AD mice. When the training was completed, the place of the platform was removed and the mice were given 60 s to find the missing platform for the probe trial. As shown in Fig. 8f , the M 3 nanosweeper-treated AD mice exhibited spatially oriented swimming behavior and shorter latencies than AD control mice. These outcomes were further confirmed by the percentage of time spent in the target quadrant (Fig. 8g) . The number of times M 3 nanosweeper-treated mice entered the small target zone was 2.4, which was greater than that of the AD mice (1.6 times). In order to evaluate long-term therapetuic effect, M 3 nanosweeper was utilized to treat APPswe/PS1dE9 transgenic mice every other day for one month, and the MWM was tested two month post-treatment. The searching ability for the hidden platform of AD mice treated with M 3 nanosweeper was obviously enhanced (Supplementary Fig. 17 ), similar as the above results, revealing that the excellent long-term therpeutic effects of M 3 nanosweeper. The systemic toxicity of M 3 was further investigated by hematology and histopathology assays ( Supplementary  Figs. 18 and 19) . No significant differences were detected in pathological signs (heart, liver, spleen, lung, and kidney) between the M 3 -treated group and the control groups (WT and AD). All of above results suggested that M 3 did not cause any obvious side effects and could be used safely as a biomaterial with excellent rescue of memory deficits in AD transgenic mice.
Discussion
In summary, we successfully developed a multifunctional peptidepolymer based nanosweeper (M 3 ), which could specifically capture Aβ via recognition and co-assembly with Aβ, followed by delivery of Aβ into cells. The nanosweeper promoted degradation of Aβ through the upregulation of autophagy. Both in vitro and Preparation of peptides. Firstly, acryl-CS was obtained as our previous reports. Peptide CFFVLKG-PEG (abbreviate to K) and CGGAAKG-PEG (abbreviate to K') were prepared by standard solid phase peptide synthesis techniques using F moccoupling chemistry. Acryl-CS (0.021 g, 0.1 mM for acrylamide bonds) was dissolved in PBS solution ( The Aβ nanofibril (20 μM) and the co-assembly solutions were obtained after incubating 24 h at 37°C. 10 μL of the solutions were dropped onto a copper mesh for 5 min, subsequently removed most of the liquid through a filter paper. 10 μL of uranyl acetate solution was employed to stain the samples for 5 min, followed by drying the spare liquid with the filter. Finally, the copper mesh was washed with 10 μL of deionized water, which was blotted after staining and dried at room temperature. Confocal laser scanning microscopy (CLSM) observation. The N2a cells incubated with and without M 3 , M K , and M B were investigated on a Zeiss LSM710 confocal laser scanning microscope (Jena, Germany). N2a cells were seeded in complete DMEM media in a humidified atmosphere with 5% CO 2 and then cultured at 37°C for a night. For co-localization analysis, the medium was replaced by 1 mL of serum free fresh medium containing 20 μg (M 3 , M K , and M B ) Cy5-labeled nanoparticles, 20 μM FITC-labeled Aβ. Then the cell were cultured with the serum free fresh medium for another 2 h and washed with PBS for 3 times. After replacement of the medium with PBS, cells were imaged using a Zeiss LSM710 confocal laser scanning microscope with a ×63 objective lens. Morris water maze (MWM) experiment. Animal experiments were carried out complying with NIH guidelines for the Care and Use of Laboratory Animals, and the study the protocol was approved by the Institutional Animal Care and Use Committee of National Center for Nanoscience and Technology, China. All animals were obtained from Beijing HFK bioscience Co., Ltd. (Beijing, China). The non-Tg C57 mice were regarded as wild type mice (WT mice). The APPswe/ PS1dE9 transgenic mice (AD mice) were divided into two group, AD group and M 3 group (3 mice per group). All mice were male, and 9 month old, which intravenously administered PBS and M 3 nanoparticles, respectively. All mice were trained and tested in a water maze with a diameter of 1.1 m. The maze was filled with water and drained daily. The temperature of the water was maintained at 22 ± 1°C. The platform (0.1 m in diameter) was immobilized to 1 cm under the water surface during the training period, whereas the starting points were counter balanced. From the first day to the fourth day during training, the mice were measured four times from four diversed positions around the border of the maze in a semirandom order with 60 s latent period to reach the platform. If the animal find the hidden platform successfully within 60 s, it was allowed to stay on the platform for 15 s. If it failed to find the platform, the mice had to be placed on the platform for 15 s. The motional orbits of each mice was recorded and studied using a computerized video-tracking system. When the last learning trial was finished, the memory capacity of each mice were explored by a probe trial without the platform. Every trained animal was allowed to swim freely for 60 s, with two initial sites far away from the targeted platform. The time each mouse spent in searching for the platform in the quadrant where the platform used to be (target quadrant), and the number of times it crossed the target quadrant was recorded.
Immunohistochemical analysis and nissl staining. After the MWM test, the mice were euthanized. The tissue sections in the coronal plane at 40 µm on a freezing sliding microtome from the genu of the corpus callosum through the caudal extent of the hippocampus (3 µm-thick, 4 sections/mouse, 3 mice/group). For qualitative analysis of Aβ immunoreactivity, half sections were immunostained as described 43 with the following Aβ antibodies: Rabbit Anti-beta-Amyloid 1-42 (CT antibody) (bs-0076R, 1:200, Bioss, Beijing, China) and Anti-rabbit IgG (H + L) Aβ Hrp (074-1506, 1:200, KPL, Massachusetts, USA). The sections were observed under a microscope (XSP-C204, COIC, China). Pictures were acquired with a digital camera and analyzed with the ImageJ software. The area occupied by Aβ plaques was quantified as the percent surface area occupied in the delineated hippocampus. The plaques were quantified as the ratio of plaques vs corresponding hippocampal area and the detailed process was shown as follows: The ratio of plaques vs hippocampal area (R%) was calculated based on R% = S t /S × 100%. S t is the total area of plaques, and the S t = S 1 + S 2 + S 3 + …, where the S 1 , S 2 , S 3 … indicates the area of each plaques. S is the analytical hippocampal area. For Nissl staining, half sections were stained with cresyl violet for Nissl body staining in the neurons. The sections were examined and photographed under a microscope (Nikon Eclipse E100) with DS-U3 DS Camera Control Unit. The number of staining cells was counted at 400× magnification in blinded manner, only structures of appropriate size and shape were demonstrated clearly. The final results were shown as mean ± SD (n = 6).
Statistical analysis. All data are reported as mean ± standard deviation (s.d.). The in vitro experiments were performed in three independent experiments with at least three technical replicates. The in vivo experiments were performed with 3-4 mice for each group. Statistical analysis of the samples was performed using Student's t-test, and P value of <0.05 was considered significant.
Data availability. The data that support the findings of this study are available within the article, its Supplementary Information files and from the corresponding author upon reasonable request.
Received: 8 May 2017 Accepted: 18 April 2018
